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Mortality rates and the causes of death
related to diabetes mellitus in Shanghai
Songjiang District: an 11-year retrospective
analysis of death certificates
Meiying Zhu1†, Jiang Li2*†, Zhiyuan Li1, Wei Luo1, Dajun Dai3, Scott R. Weaver4, Christine Stauber4, Ruiyan Luo4
and Hua Fu1
Abstract
Background: China is one of the countries with the highest prevalence of diabetes in the world. We analysed all
the death certificates mentioning diabetes from 2002 to 2012 in Songjiang District of Shanghai to estimate morality
rates and examine cause of death patterns.
Methods: Mortality data of 2654 diabetics were collected from the database of local CDC. The data set comprises
all causes of death, contributing causes and the underlying cause, thereby the mortality rates of diabetes and its
specified complications were analysed.
Results: The leading underlying causes of death were various cardiovascular diseases (CVD), which collectively
accounted for about 30 % of the collected death certificates. Diabetes was determined as the underlying cause of
death on 28.7 %. The trends in mortality showed that the diabetes related death rate increased about 1.78 fold in
the total population during the 11-year period, and the death rate of diabetes and CVD comorbidity increased 2.66
fold. In all the diabetes related deaths, the proportion of people dying of ischaemic heart disease or cerebrovascular
disease increased from 18.0 % in 2002 to 30.5 % in 2012. But the proportions attributed directly to diabetes showed
a downtrend, from 46.7–22.0 %.
Conclusions: The increasing diabetes related mortality could be chiefly due to the expanding prevalence of CVD,
but has nothing to do with diabetes as the underlying cause. Policy makers should pay more attention to primary
prevention of diabetes and on the prevention of cardiovascular complications to reduce the burden of diabetes on
survival.
Background
Diabetes is a global epidemic with nearly 350 million
cases [1]. According to the data from the World Health
Organization (WHO), over 3 million people die world-
wide from diabetes and its related complications every
year [2]. China is the country with the second highest
diabetes rate in the world [3]. The development and
expansion of China’s economy over the past decade, has
led to dramatic changes in people’s lifestyle and an
increase in life expectancy, not only in cities but also in
rural areas. But changes in lifestyle and diet associated
with an improvements in socioeconomic status may
contribute to an increasing diabetes burden in China
[4, 5]. A national survey conducted in 2009 estimated
age-standardized prevalences of 9.7 and 15.5 % for dia-
betes and prediabetes, which accounted for 92.4 million
and 148.2 million adults, respectively [6]. These estimates
are approximately tripled and quintupled, respectively,
from earlier estimates from survey data collected in early
1990s [7].
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Many people with diabetes do not die from hypergly-
caemia itself; the top causes of death are various com-
plications, among which cardiovascular diseases and
nephropathy are the most common [8–10]. This results
in a difficulty for estimating the burden of diabetes on
survival. There are normally two measures estimating
the burden of diabetes, diabetes related death and dia-
betes as the underlying cause of death. For the diabetes
related death, underreporting in death certificate is very
common worldwide. It was found that only about 40 %
diabetes had been recorded on the death certificates of
decedents with known diabetes [11–18]. On the other
hand, the state of existing routine vital statistics world-
wide may omit mention of diabetes as an underlying
cause of death [19]. The recording cause of death can
also be affected by subjective judgement of physicians
and different coding systems among countries [20, 21].
In 1980s, China’s Ministry of Health established the vital
registration system (MOH-VR) to record the fact and
cause of death. However, the accuracy and representative-
ness of data from the system are biased due to some limi-
tations such as variability in quality control measures and
coverage between different areas [22]. Therefore, the
Ministry of Health instructed departments of health at
the province and county levels to establish the Chinese
Disease Surveillance Points System (DSP) from which
cause specific mortalities are monitored for a nationally
representative sample. In 2013, there were 605 DSP sites
nationwide covering over 1 % of the national population
[22]. Shanghai Songjiang District is one of the DSP sites
since 1990s.
In the present study, a file of coded death certificate
data was supplied by the Songjiang Center for Disease
Control and Prevention (CDC). The data set comprises
all causes of death including the contributing causes and
the underlying cause associated with diabetes mellitus
between January 2002 and December 2012. From these
data, we described the changing patterns of mortalities
related to diabetes, and analysed its health burden for
the last decade. To the best of our knowledge, this is the
first study reporting epidemiological data concerning
mortalities related to diabetes in China.
Methods
Songjiang District is one of the administrative regions of
the Shanghai municipality located to the South of the city
centre, covering 15 communities including rural and
urban areas. According to the data from the government,
the population of Songjiang District was approximately
500,000 in 2002. With a natural population growth rate of
about 15 per thousand, the registered permanent residents
increased to 583,000 in 2012.
Data on mortality status were ascertained through death
certificates completed by local physicians, validated by
specific staff, and archived (electronic data) with the local
CDC. The detailed working procedure for mortality regis-
tration and surveillance is described elsewhere [22, 23].
The information in the death certificate includes demo-
graphic variables for each decedent, such as sex, date of
birth and date of death, all causes of death (related and
underlying), as well as some other death status such as
death place, diagnostic basis of death, the level of the
institute providing diagnosis etc. By considering ethical
issues, we used anonymized death registration data with
hiding personal identification, so that no individual
could be identified. Therefore individual institutional
approval was unnecessary. The dataset can be found in
Additional file 1.
The present study includes data for all deaths related
to diabetes (ICD-10 E10-E14) among the permanent res-
idents, during the 11-year period from 2002 to 2012.
The fourth character subdivisions under ICD-10 E10-
E14 were used to analyse diabetic complications.
Statistical analysis was performed using the PASW sta-
tistics version 18 (SPSS) for Windows. Values of p < 0.05
were deemed as statistically significant. Normally distrib-
uted continuous clinical data were presented as means ±
SD, whereas non-normally distributed continuous data
were presented as median and interquartile range (IQR;
P25–P75), unless otherwise stated. To test temporal
trends, we performed the Spearman rank correlations
of mortalities and time. Interval estimations (95 % con-
fidence interval, 95 % CI) were used to analyse statis-
tical significances of proportion differences between
2002 and 2012.
Results
Description of total sample
There were 2654 diabetes related deaths in the period
2002–2012 (1269 men, 1385 women). This represents
6.6 % (2654/40059) of all deaths in Songjiang District.
The age of the deceased ranged between 18 and 101 years,
median 76 (IQR: 68 – 82) years. Of these deaths, there
were 21 (0.8 %) type 1 diabetics, 1168 (44.0 %) type 2 dia-
betics, 1462 (55.1 %) cases with unspecified diabetes
(ICD-10 E14), and 3 cases that were allocated to other
specified diabetes (ICD-10 E13). Overall, diabetes was de-
termined as the underlying cause of death on 28.7 % (762
cases) of the collected death certificates.
For 2332 deceased, the diagnosis of the cause of death
was based on medical records, which accounts for 87.9 %
of all the involved subjects; 268 (10.1 %) deaths were diag-
nosed based on pathologic findings; 36 (1.4 %) deaths were
determined in surgical operations; and 14 (0.5 %) deaths
were determined by executed autopsy. There were 1495
(56.3 %) home deaths and 1045 (39.4 %) deaths occurred
in health facilities. The remaining 114 (4.3 %) deaths died
on the way to hospital or somewhere else.
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Table 1 shows all of the underlying causes of death
for the subjects with diabetes from 2002 to 2012. The
leading causes of death were cardiovascular diseases,
diabetes mellitus, neoplasms, and respiratory diseases.
These accounted for 88.4 % of all the causes of death.
Women more frequently died from unspecified diabetes,
cerebrovascular diseases and injury than men; whereas the
cause of death for men was more frequently attributed to
tumour, hypertension and respiratory disease than women
(p < 0.05, Chi-square test).
The burden of diabetic complications
Of the 2654 diabetes related deaths, 1943 (73.2 %) de-
ceased were diagnosed with comorbidity of diabetes and
circulatory system diseases (ICD-10 I00–I99, excluding
I46); and no statistical difference was shown by gender
(p = 0.10, Chi-square test). Diabetes specified complica-
tions were determined according to the fourth character
subdivisions under ICD-10 codes E10–E14. The distri-
bution of complications in the deceased with diabetes as
underlying cause of death is shown in Fig. 1. In addition
to the circa 38 % deceased without complications, the
leading causes were renal complications, other specified
complications, multiple complications, and peripheral
circulatory complications, which collectively accounted
for over 45 % of deaths where diabetes was the under-
lying cause.
Trends in mortality and proportion during the 11-year
period
Of all the diabetes related deaths, type 2 diabetes and the
unspecified diabetes (ICD-10 E14) accounted for over 97 %
of cases in each of every year from 2002 to 2012. However,
there were divergent trends: the proportion of unspecified
diabetes declined, whereas the proportion of type 2 dia-
betes presented an ascendant pattern. For more detail
please find in Additional file 2: Figure S1.
Annual crude mortality rates for all-causes were rela-
tively stable during the 11-year period ranging 63.19 per
ten thousand to 74.39 per ten thousand for the Songjiang
population (see Additional file 3: Table S1). The diabetes
related death rate was 2.44 per ten thousand in 2002, in-
creasing to 6.78 per ten thousand in 2012. The death rates
of diabetes and cardiovascular diseases comorbidity exhib-
ited the same rising trend, from 1.52 per ten thousand in
2002 to 5.55 per ten thousand in 2012. The mortalities of
Table 1 Causes of death for diabetics in Songjiang District 2002–2012
Total no. (%) Male Female P value†
All causes 2654 (100) 1269 (100) 1385 (100) -
Diabetes as the underlying cause 762 (28.7) 323 (25.5) 439 (31.7) <0.01
Type 1 diabetes (E10) 15 (0.6) 7 (0.6) 8 (0.6) 0.93
Type 2 diabetes (E11) 306 (11.5) 134 (10.6) 172 (12.4) 0.13
Unspecified diabetes (E14) 441 (16.6) 182 (14.3) 259 (18.7) <0.01
Infections (A00-B99) 68 (2.6) 32 (2.5) 36 (2.6) 0.90
Neoplasms (C00-D48) 612 (23.1) 339 (26.7) 273 (19.7) <0.01
Mental and behavioural disorders (F00-F99) 9 (0.3) 4 (0.3) 5 (0.4) 1.00‡
Neuropathies (G00-G99) 15 (0.6) 8 (0.6) 7 (0.5) 0.67
Cardiovascular diseases (CVD) (I00-I99)a 793 (29.9) 362 (28.5) 431 (31.1) 0.15
Hypertension (I10-I15) 25 (0.9) 17 (1.3) 8 (0.6) 0.04
Ischaemic heart diseases (I20-I25) 232 (8.7) 112 (8.8) 120 (8.7) 0.88
Cerebrovascular diseases (I60-I69) 522 (19.7) 226 (17.8) 296 (21.4) 0.02
Other CVDsa 14 (0.5) 7 (0.6) 7 (0.5) 0.86
Respiratory diseases (J00-J99) 178 (6.7) 113 (8.9) 65 (4.7) <0.01
Diseases of the digestive system (K25-K93) 63 (2.4) 33 (2.6) 30 (2.2) 0.46
Diseases of the musculoskeletal system and connective tissue (M00-M99) 14 (0.5) 4 (0.3) 10 (0.7) 0.18‡
Nephropathy (N00-N19) 16 (0.6) 8 (0.6) 8 (0.6) 0.86
Other disorders of the genitourinary system (N20-N99) 6 (0.2) 4 (0.3) 2 (0.1) 0.43‡
External causes (V01-Y98) 111 (4.2) 38 (3.0) 73 (5.3) <0.01
Othersa 7 (0.3) 1 (0.1) 6 (0.4) 0.13‡
Data are shown as frequencies and percentages
†Chi-square test, unless otherwise stated
‡Fisher’s exact test
aThe ICD-10 code I46 is not included in CVD category but in the category of others, since it is not a cause of death referring to CVD
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diabetes as the underlying cause rose slightly from 1.14
per ten thousand in 2002 to 1.49 per ten thousand in
2012. These rates are shown in Fig. 2. The Spearman’s rho
were −0.24 (p = 0.31), 0.89 (p < 0.01), 0.49 (p = 0.04), and
0.89 (p < 0.01) for the correlations between all-cause mor-
tality and the year of death, between diabetes related death
rate and the year of death, between the mortality of
diabetes as the underlying cause and the year of death,
between the death rate of diabetes and CVD comorbidity
and the year of death, respectively.
Of all diabetes related deaths, the proportions attrib-
uted directly to diabetes as the underlying cause de-
creased from 46.7 % in 2002 to 22.0 % in 2012 (95 % CI
of the rate difference ranged from 15.0–34.5 %). The
Fig. 1 The distribution of diabetes specified complications in the decedents with diabetes as underlying cause of death in 11 years
Fig. 2 Changing patterns in crude death rates from 2002 to 2012. The denominators are the average total population in Songjiang District for
every year
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corresponding Spearman’s rho = −0.92 (p < 0.01). The
proportions of deceased without complications followed
a similar downtrend from 24.6 in 2002 to 6.3 % in 2012
(95 % CI of the rate difference ranged from 10.3–26.3 %).
The Spearman’s rho = −0.93 (p < 0.01). In comparison, the
proportions of deceased diabetics who died from renal
complications varied within a narrow range, from 6.6 % in
2002 to 5.1 % in 2012 (95 % CI of the rate difference
ranged from −3.4–6.4 %). The Spearman’s rho = −0.45
(p = 0.17). The proportions of deceased diabetic due to
cardiovascular diseases showed an ascendant trend, of
which ischaemic heart diseases as underlying cause of
death increased from 3.3 % in 2002 to 9.8 % in 2012
(95 % CI of the rate difference ranged from −10.9–2.3 %),
and cerebrovascular diseases increased from 14.8 % in
2002 to 20.7 % in 2012 (95 % CI of the rate difference
ranged from −13.4–1.5 %). The values of Spearman’s rho
were 0.70 (p = 0.02) and 0.60 (p = 0.05), respectively. These
changing patterns are shown in Fig. 3.
Discussion
Trends in mortalities tend to reflect the level of eco-
nomic development and the changing pattern of health
services of a country or region [24, 25]. In the present
study, it showed an increased trends in diabetes related
mortality with growing proportions of CVD prevalence
and mortality in a Chinese population. In the first dec-
ade of the 21st century, China has been one of the most
rapidly developing countries in the world with an in-
crease in life expectancy and changes in lifestyle [4]. The
crude death rates for China, including for Shanghai [26]
and Songjiang have varied only slightly during this
decade, but the diabetes mortality (diabetes related
death) increased about 1.78 fold (see Fig. 2) in Song-
jiang District. Similarly, the prevalence of diabetes has
increased dramatically during a similar period in
China, from 5.5 % in 2001 [27] to 11.6 % in 2010[28].
This reveals that the increased diabetics should be
owed to the growth of incidence, which should be fas-
ter than the growth of mortality. Certainly, the devel-
opment of medical techniques should help to detect
more and more individuals with undiagnosed diabetes
since last decades, which could led to a pseudo in-
crease of incidence. In spite of the striking increase of
diabetes related death (by 178 %), the mortality of dia-
betes as the underlying cause increased only 30 %. In
addition, the proportion of diabetes as the underlying
cause reduced significantly, of which especially the
proportion of subject without complications (Fig. 3).
This may reflect improvement of health service like ef-
fective treatment of hyperglycaemia and efforts to pre-
vent diabetic complications (not counting CVD) by
local health care systems. On the other hand, it sug-
gests that the central and local governments should
pay more attention to primary preventions aimed at
lowering the incidence and ultimately to reduce the bur-
den of diabetes. Moreover, the descending proportion of
unspecified type may be attributable to improvements in
proper diagnosis by clinicians. That is, the types of dia-
betes for a large amount of decedents had been already
clarified and/or recorded before death. This is in conform-
ity with the progress of local health service (Data from
Fig. 3 Changing patterns in proportions of the underlying cause of death for diabetes, cardiovascular diseases, and diabetes without complications.
The denominators are the number of diabetes related deaths for every year
Zhu et al. BMC Endocrine Disorders  (2015) 15:45 Page 5 of 8
“Statistic Yearbook of Songjiang” 2004 – 2013,published
by local government).
People with type 2 diabetes have an increased risk of de-
veloping CVD. In the present study, 73.6 % of deceased di-
abetics had suffered from CVD, and about 30 % died
directly of CVD, which is higher than India (13.7 %) [29]
and Taiwan (19.8 %) [30], and is lower than the western
countries (49.4 % for the U.S. and 49.1 % for U.K.) [31].
But this comparison is not totally appropriate because it
can be biased by many factors including the difference of
coding system among countries, the habits of recording
physicians, the subjective judgement of them, and so on
[20, 21]. We used continuous data to describe the vari-
ation of mortality of CVD, which is more informative than
a static observation and helpful to assess the CVD burden.
The changing pattern during the 11-year period manifests
that the increasing deaths associated with diabetes should
chiefly be owed to cardiovascular diseases but have noth-
ing to do with diabetes as the underlying cause, that is,
other diabetic complications and diabetes without compli-
cations. As shown in Fig. 2, the curve of death rate for
people with diabetes and CVD comorbidity shows nearly
parallel to the curve of diabetes related mortality. In fact,
the mortality for people with comorbidity increases faster
than the mortality for all diabetics, that is, the proportion
of deceased diabetics with CVD comorbidity increased
from 62–82 % during the 11 years. However, the mortality
rate for people with other complications varied very
slightly; even the proportion of deaths without complica-
tions decreased more than three fold in the same period.
Mortality statistics are an important source of health in-
formation for analysing the burden of diseases and are
often used to assign priorities in health policy [2]. In
China, there are two sets of mortality registration systems,
the MOH-VR and the DSP. In general, the DSP provides
more representative and more accurate data than the
MOH-VR, especially in rural areas [22]. Songjiang District
is one of the national DSP sites since the last decades,
where the non-agricultural population accounted for 46 %
in 2003 and 83 % in 2012 (Data from “Statistic Yearbook
of Songjiang” 2004 – 2013). Considering that Songjiang
locates in the most developed area in China, the number
of hospital beds per thousand people was 6.5 in 2003 and
8.0 in 2012, that is, the local health service are quantita-
tively and qualitatively in the forefront of the country [26],
thus the accuracy of the data should be in a higher level
comparing with other areas of the country.
In general, estimation of diabetes mortality is challen-
ging due to various reasons. For example, these challenges
stem from people with diabetes most frequently dying of
cardiovascular diseases or renal failure, and the physicians
who record and determine the causes of death may miss
and underestimate the contributions of diabetes on death
[11–19, 32]. In the present study, the death certification in
Songjiang listed up to seven causes contributing to death,
of which the underlying causes were determined by certi-
fied doctors. We collected all records mentioning diabetes
in the certificates to assess contributions of diabetes on
death; thus the estimate we calculated could be very simi-
lar to a mortality statistic for the people with diabetes.
Although we are confident of the higher quality of
data, data from death certificates have potential to dis-
tort mortality rates because of the ineluctability of incor-
rect reporting. One possible explanation for the steep
increase in diabetes related deaths could be increased
awareness of the disorder. Since the Center for Non-
communicable Disease of the Chinese Center for Disease
Control and Prevention (China CDC) was established in
2002, surveillance on chronic diseases, such as hyperten-
sion and diabetes etc., was gradually highlighted by local
CDCs. Therefore, an underestimation of mortality
should be taken into account, especially in the earlier
stage of the investigation. Furthermore, the International
Statistical Classification of Diseases and Related Health
Problems (known as ICD) facilitates mortality statistics
by standardizing causes of death [33], and also request
the capacities of certifying doctors in the correct ICD
procedures [34]. But even in developed countries there
was often substantial use of ICD codes for unknown and
ill-defined causes [33]. Also ill-defined causes (ICD-10
codes R00-R99) existed in our data (230 cases for the
contributing causes, but none was in the underlying
cause), that would also affect the validity of our esti-
mates. Death certificate is one of the most important
sources of data regarding people health, but the data
quality is often concerned. There were few studies con-
cerning the accuracy of recorded cause of death of dia-
betic decedents in China. Therefore, assessment and
further improvement of death certificate should become
a key emphasis in work of the health care system in the
future, which would help us to correctly understand the
burden of diabetes on survival [35].
Another limitation relates to the representativeness of
local population. Due to China’s household registration
system, only permanent residents were recorded by local
CDCs. People who lived in Songjiang but were registered
in other regions were not included in the present study.
Because the majority of these people were young adults
who worked in Songjiang, the diabetes related mortal-
ities for the total population would be smaller than the
data in the present study. Moreover, though the data of
the study cannot represent the characteristics of entire
Chinese population, it should be also meaningful and
suggestive for policymakers. Since Shanghai is one of the
most developed area of China and has a very higher
proportion (>20 %) of old people (60 years or older,
permanent residents) [36]. This is and will be a similar
situation in other areas of China.
Zhu et al. BMC Endocrine Disorders  (2015) 15:45 Page 6 of 8
The present survey provides only information restricted
in deceased diabetics, therefore the results should be ex-
plained carefully. For example, although the proportions
of those who died from CVD rose rapidly from 2002 to
2012, we cannot attribute the increase of CVD mortality
only to the prevalence of diabetes. Because we did not col-
lect mortality data of people who did not have diabetes,
we do not know the situation of CVD mortality for them
[37]. In contrast, from the changing proportions it could
be clearly determined that CVD contributed more and
more on diabetes deaths from 2002 to 2012.
Conclusions
There was an increase in diabetes related mortality over
the past decade. The increased mortality appears mostly
attributed to the prevalence of cardiovascular diseases.
Therefore, policy makers should pay more attentions to
diabetes primary prevention to reduce the incidence rate
while also placing a priority on the prevention of cardio-
vascular diseases to reduce the burden of diabetes on
survival.
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